Theophylline, pentostatin (Nipent), and chlorambucil: a dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders.

Source:http://linkedlifedata.com/resource/pubmed/id/10877050

Download in:

View as

General Info

PMID
10877050